Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Iron (parenteral Preparations), Atc B03ac01 F. D.z. 01.11.25-31.10.27 (plus Extension Option 1x12 Month) 2026-03-15
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Follitropin Beta, Atc G03ga06 For The Time 01.11.2025 - 31.10.2027 2026-03-15
Germany Pharmaceutical Discount Contracts In Accordance With Section 130a (8) Sgb V As Part Of Open House Procedures 2026-03-15
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To § 130a Abs. 8 Sgb V To The Active Substance Raltegravir, Atc J05aj01 For The Time 01.11.2025 31.10.2027 2026-03-15
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To § 130a Abs. 8 Sgb V On The Active Substance Tiotropium Bromide Exclusively In The Dafo Solution For Inhalation, Atc R03bb04 F. D. Z. 01.11.25 31.10.27 2026-03-15
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Tiotropium Bromide Exclusively In The Dafo Solution For Inhalation, Atc R03bb04 F. D. Z. 01.11.25 - 31.10.27 2026-03-15
Germany Pimecrolimus; Atc-code: D11ah02 2026-03-15
Germany Pharmaceutical Discounts According To § 130a Para. 8 Sgb V As Part Of Openhouse Processes 2026-03-15
Germany Pyridostigmine; Excessive Tablets; Atc Code: N07aa02 2026-03-15
Germany Oxybutynin; Solution For Intravesical Use; Atc Code: G04bd04 2026-03-15
Whats app